What are the available balloon sizes for percutaneous transvenous mitral commissurotomy (PTMC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Balloon Sizes for PTMC

The Inoue balloon for percutaneous transvenous mitral commissurotomy (PTMC) is available in sizes ranging from 24 mm to 30 mm, with selection traditionally based on patient height: 24 mm for patients <147 cm, 26 mm for 147-160 cm, 28 mm for 160-180 cm, and 30 mm for >180 cm. 1

Standard Balloon Sizing Algorithm

The conventional approach to Inoue balloon selection follows a height-based protocol 1:

  • 24 mm balloon: Patients with height <147 cm
  • 26 mm balloon: Patients with height 147-160 cm
  • 28 mm balloon: Patients with height 160-180 cm
  • 30 mm balloon: Patients with height >180 cm

Critical Modifications to Standard Sizing

Smaller balloons than the recommended size should be selected in specific high-risk scenarios 1:

  • Severe pathological valve changes: Particularly valves showing mixed strong and weak echoes in leaflets combined with strong commissural echoes on 2D echocardiography 1
  • Advanced patient age: Older patients require downsizing to prevent complications 1
  • Suboptimal valve anatomy: Patients with Wilkins score >8 or significant calcification 2

Stepwise Dilatation Technique

The procedure employs progressive balloon inflation at increasing diameters rather than a single inflation 1:

  • Begin with smaller diameter inflations
  • Use Doppler echocardiography between inflations to assess mitral regurgitation, valve area increase, and commissure separation 1
  • Monitor for disappearance of balloon waist under fluoroscopy as a key decision point 1
  • Continue stepwise increases until adequate gradient relief without significant mitral regurgitation 1

Alternative Sizing Methods

Emerging evidence supports 3D transesophageal echocardiography-guided sizing based on mitral annulus geometry 3:

  • Formula: Balloon size = 0.0684 × lateral-medial diameter (from 3D software) + 24.309 3
  • This method may provide more precise sizing than height-based formulas 3
  • Particularly useful for avoiding undersizing (residual stenosis) or oversizing (significant mitral regurgitation) 3

Double-Balloon Technique

The Multi-Track system offers an alternative double-balloon approach using a single wire 4:

  • Allows simultaneous dilatation when combined valvular disease is present 4
  • Cost-effective and technically simpler than traditional double-balloon methods 4
  • Can be used with different balloon sizes in the same procedure 4

Pediatric Considerations

In children <12 years, using balloons 1-3 mm smaller than the height-recommended size achieves comparable results with potentially improved safety 5:

  • Final mitral valve areas were similar between standard and reduced sizing (1.66 vs 1.61 cm²) 5
  • Incidence of significant mitral regurgitation was not increased with smaller balloons 5
  • This approach is particularly relevant given the smaller anatomic structures in pediatric patients 5

Common Pitfalls to Avoid

Do not select balloon size based solely on height without considering valve pathology 1. The presence of severe calcification, mixed echogenicity patterns, or advanced age mandates downsizing regardless of the height-based recommendation 1.

Avoid single-step inflation to maximum diameter 1. The stepwise technique with echocardiographic monitoring between inflations is essential to prevent severe mitral regurgitation, which occurs in 2-10% of cases 2.

Do not proceed without transesophageal echocardiography to exclude left atrial thrombus 6, 7, as this is an absolute contraindication that cannot be adequately assessed with transthoracic imaging alone 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Balloon Valvuloplasty for Rheumatic Mitral Stenosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Mitral Balloon Valvuloplasty Procedure and Outcomes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the best recommendation for a 31-year-old nulligravida (woman who has never been pregnant) woman with mitral stenosis (mitral valve area of 1.2 cm2) and symptoms of exertional dyspnea (shortness of breath on moderate exertion), who is planning to conceive soon?
What is the recommended method for determining balloon size for Balloon Mitral Valvuloplasty (BMV) using the lateral-medial left atrial distance?
What is the step-by-step procedure for Percutaneous Transvenous Mitral Commissurotomy (PTMC)
What are the treatment options for a patient with severe mitral stenosis?
What are the common causative agents, classical presentations, and histological findings of central nervous system (CNS) infections, including bacterial, viral, fungal, and parasitic infections?
What is the recommended management for an adult patient with impaired renal function, proteinuria, and hypertension, possibly with pre-existing conditions such as diabetes or hypertension?
Can magnesium supplementation cause dysuria (painful urination) and urinary frequency in patients with or without a history of urinary tract problems or kidney disease?
What is the most direct diagnostic approach for a patient suspected of having tuberculosis (TB) of the skin?
What are the treatment options for central nervous system (CNS) infections caused by Streptococcus agalactiae, Candida, or enterovirus in patients, including neonates and immunocompromised individuals?
How does tretinoin work for treating acne in adolescents and young adults?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.